Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 61.96

-3.2%

Nov 3 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: IRWIN JAMES FRANKEL who wrote (3160)	3/24/2001 10:19:05 AM
From: IRWIN JAMES FRANKEL	Read Replies (1) of 52153

Screening the table The table gave us a fair handle on the cash per share net of long term debt and the percentage it bears to the market price. I wanted to take a look at the cash burn rate as well. I used the Signals February table, here is the link: signalsmag.com So I screened those companies in the table we created for companies which had over 40% NetC%P and where the Survival index in Signals data was over 4.0 or N/A (no burn rate). Here is what is left: xxxx --- NetC%P --- Survival Index CEGE -- 164% ----- 824 CRA --- 97% ----- 6.1 INCY -- 46% ----- 21.2 ITMN -- 50% ----- 9.1 LEXG -- 50% ----- 33.5 Caution: I did this very quickly so it is likely I missed some things. Feel free to correct me where I erred. ij

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next